Christopher Assaid

4.2k total citations
21 papers, 1.8k citations indexed

About

Christopher Assaid is a scholar working on Psychiatry and Mental health, Surgery and Physiology. According to data from OpenAlex, Christopher Assaid has authored 21 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 5 papers in Surgery and 5 papers in Physiology. Recurrent topics in Christopher Assaid's work include Migraine and Headache Studies (7 papers), Trigeminal Neuralgia and Treatments (4 papers) and Sympathectomy and Hyperhidrosis Treatments (3 papers). Christopher Assaid is often cited by papers focused on Migraine and Headache Studies (7 papers), Trigeminal Neuralgia and Treatments (4 papers) and Sympathectomy and Hyperhidrosis Treatments (3 papers). Christopher Assaid collaborates with scholars based in United States, United Kingdom and Netherlands. Christopher Assaid's co-authors include David W. Dodick, Christopher Lines, Tony W. Ho, Xiaoyin Fan, Robert Bachman, Michel D. Ferrari, Heather Leibensperger, Samar Froman, James Kost and Paul Winner and has published in prestigious journals such as The Lancet, Journal of the American Statistical Association and Neuropsychopharmacology.

In The Last Decade

Christopher Assaid

21 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Assaid United States 18 1.0k 621 615 250 195 21 1.8k
Geir Bråthen Norway 24 809 0.8× 213 0.3× 475 0.8× 166 0.7× 159 0.8× 66 2.1k
Robert Croop United States 18 1.4k 1.3× 858 1.4× 594 1.0× 167 0.7× 221 1.1× 106 2.0k
Carmine Marini Italy 24 422 0.4× 321 0.5× 324 0.5× 243 1.0× 132 0.7× 57 3.0k
Yu-Hui Liu China 23 284 0.3× 78 0.1× 926 1.5× 372 1.5× 223 1.1× 73 1.9k
Luigi Francesco Iannone Italy 20 417 0.4× 174 0.3× 228 0.4× 52 0.2× 134 0.7× 73 1.1k
Neil H. Raskin United States 26 1.3k 1.2× 940 1.5× 689 1.1× 125 0.5× 244 1.3× 51 2.4k
N. N. Yakhno Russia 18 405 0.4× 205 0.3× 539 0.9× 273 1.1× 60 0.3× 90 1.7k
Antonio Siniscalchi Italy 25 506 0.5× 119 0.2× 156 0.3× 141 0.6× 755 3.9× 103 2.1k
Ed Whalen United States 18 649 0.6× 117 0.2× 958 1.6× 108 0.4× 123 0.6× 59 2.0k
Brendan Kelley United States 16 302 0.3× 96 0.2× 244 0.4× 127 0.5× 103 0.5× 33 973

Countries citing papers authored by Christopher Assaid

Since Specialization
Citations

This map shows the geographic impact of Christopher Assaid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Assaid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Assaid more than expected).

Fields of papers citing papers by Christopher Assaid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Assaid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Assaid. The network helps show where Christopher Assaid may publish in the future.

Co-authorship network of co-authors of Christopher Assaid

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Assaid. A scholar is included among the top collaborators of Christopher Assaid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Assaid. Christopher Assaid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arribas, José Ramón, Sanjay Bhagani, Suzana M. Lobo, et al.. (2021). Randomized Trial of Molnupiravir or Placebo in Patients Hospitalized with Covid-19. NEJM Evidence. 1(2). EVIDoa2100044–EVIDoa2100044. 86 indexed citations
2.
Caraco, Yoseph, Gordon Crofoot, Pablo Andrés Moncada, et al.. (2021). Phase 2/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized Adults. NEJM Evidence. 1(2). EVIDoa2100043–EVIDoa2100043. 68 indexed citations
3.
Muccino, David, Alyn H. Morice, Surinder S. Birring, et al.. (2020). Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough. ERJ Open Research. 6(4). 284–2020. 42 indexed citations
4.
Woo, Tiffany, et al.. (2018). Incidence of hypersensitivity and anaphylaxis with sugammadex. Journal of Clinical Anesthesia. 47. 67–73. 21 indexed citations
5.
Voss, Tiffini, Jerry Li, Jeffrey L. Cummings, et al.. (2018). Randomized, controlled, proof‐of‐concept trial of MK‐7622 in Alzheimer's disease. Alzheimer s & Dementia Translational Research & Clinical Interventions. 4(1). 173–181. 45 indexed citations
6.
Herring, W. Joseph, Tiffany Woo, Christopher Assaid, et al.. (2017). Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies. Journal of Clinical Anesthesia. 41. 84–91. 33 indexed citations
7.
Herring, W. Joseph, et al.. (2017). Orexin Receptor Antagonism in Painful Diabetic Neuropathy. Clinical Journal of Pain. 34(1). 37–43. 7 indexed citations
8.
Rosenberg, Jacob, W. Joseph Herring, Manfred Blobner, et al.. (2017). Deep Neuromuscular Blockade Improves Laparoscopic Surgical Conditions: A Randomized, Controlled Study. Advances in Therapy. 34(4). 925–936. 39 indexed citations
9.
10.
Voss, Tiffini, Richard B. Lipton, David W. Dodick, et al.. (2016). A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine. Cephalalgia. 36(9). 887–898. 191 indexed citations
11.
Ho, Tony W., Eric Pearlman, Donald W. Lewis, et al.. (2012). Efficacy and tolerability of rizatriptan in pediatric migraineurs: Results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design. Cephalalgia. 32(10). 750–765. 54 indexed citations
12.
Hewitt, David, Eric Pearlman, Mirja Hämäläinen, et al.. (2012). Long‐Term Open‐Label Safety Study of Rizatriptan Acute Treatment in Pediatric Migraineurs. Headache The Journal of Head and Face Pain. 53(1). 104–117. 10 indexed citations
13.
Hewitt, David, Sheena K. Aurora, David W. Dodick, et al.. (2011). Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine. Cephalalgia. 31(6). 712–722. 225 indexed citations
14.
15.
Thal, Leon J., Steven H. Ferris, Christopher Assaid, et al.. (2008). Rofecoxib in Patients with Mild Cognitive Impairment: Further Analyses of Data from a Randomized, Double-Blind, Trial. Current Alzheimer Research. 5(1). 73–82. 25 indexed citations
16.
17.
Assaid, Christopher. (2007). The Theory of Response-Adaptive Randomization in Clinical Trials. Journal of the American Statistical Association. 102(480). 1479–1479. 44 indexed citations
18.
Thal, Leon J., Steven H. Ferris, Louis Kirby, et al.. (2005). A Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive Impairment. Neuropsychopharmacology. 30(6). 1204–1215. 307 indexed citations
19.
Hainer, James W., Donald J. Sherrard, Suzanne K. Swan, et al.. (2002). Intravenous and subcutaneous weight-based dosing of the low molecular weight heparin tinzaparin (Innohep) in end-stage renal disease patients undergoing chronic hemodialysis. American Journal of Kidney Diseases. 40(3). 531–538. 28 indexed citations
20.
Barrett, Jeffrey S., Christopher Assaid, Michael J. Fossler, et al.. (2002). Dosing in Heavy-weight/Obese Patients with the LMWH, Tinzaparin: A Pharmacodynamic Study. Thrombosis and Haemostasis. 87(5). 817–823. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geir Bråthen Breakdown of academic impact, for papers by Robert Croop Breakdown of academic impact, for papers by Carmine Marini Breakdown of academic impact, for papers by Yu-Hui Liu Breakdown of academic impact, for papers by Luigi Francesco Iannone Breakdown of academic impact, for papers by Neil H. Raskin Breakdown of academic impact, for papers by N. N. Yakhno Breakdown of academic impact, for papers by Antonio Siniscalchi Breakdown of academic impact, for papers by Ed Whalen Breakdown of academic impact, for papers by Brendan Kelley
Rankless by CCL
2026